The President of Harvard University is the chief administrator of the university and the ex officio chairman of the Harvard Corporation. Each is appointed by and is responsible to the other members of that body, who delegate to him or her the day-to-day running of the university. The current incumbent is Drew Gilpin Faust, formerly the dean of Harvard's Radcliffe Institute for Advanced Study.Harvard is a famously decentralized university, noted for the "every tub on its own bottom" independence of its various constituent faculties. They set their own academic standards and manage their own budgets. The president, however, plays an important part in university-wide planning and strategy. Each names a faculty's dean , and grants tenure to recommended professors; however, he or she is expected to make such decisions after extensive consultation with faculty members.Traditionally, as the leader of one of the United States' most prominent universities, Harvard presidents have influenced educational practices nationwide. Charles W. Eliot, for example, originated America's familiar system of a smorgasbord of elective courses available to each student; James B. Conant worked to introduce standardized testing; Derek Bok and Neil L. Rudenstine argued for the continued importance of diversity in higher education.Recently, however, the job has become increasingly administrative, especially as the president has become increasingly responsible for conducting fund-raising campaigns. Some have criticized this trend to the extent it has prevented the president from focusing on substantive issues in higher education.Each president is a qualified academic professor in some department of the university and will, on occasion, teach courses. Wikipedia.
News Article | July 27, 2017
SEATTLE--(BUSINESS WIRE)--Starbucks Corporation (Nasdaq: SBUX) today announced entry into a definitive agreement to acquire the remaining 50% share of its East China (“East China JV”) business from long-term joint venture partners, Uni-President Enterprises Corporation (“UPEC”) and President Chain Store Corporation (“PCSC”) for approximately $1.3 billion in cash consideration in the largest single acquisition in the Company’s history. Starbucks will assume 100% ownership of approximately 1,300 Starbucks stores in Shanghai and Jiangsu and Zhejiang Provinces, building on the Company’s ongoing investments in China, its fastest-growing market outside of the United States in terms of store count. Concurrently, UPEC and PCSC will acquire Starbucks 50% interest in President Starbucks Coffee Taiwan Limited (“Taiwan JV”) and assume 100% ownership of Starbucks operations in Taiwan for approximately $175 million. Founded in 1997, the Taiwan JV currently operates approximately 410 Starbucks stores in Taiwan. “Unifying the Starbucks business under a full company-operated structure in China reinforces our commitment to the market and is a firm demonstration of our confidence in the current local leadership team as we aim to grow from 2,800 to more than 5,000 stores by 2021,” said Kevin Johnson, president and ceo, Starbucks Coffee Company. “Similar to our decision in 2011 to fully license our Hong Kong and Macau market operations, we are pleased to transition our business in the Taiwan market to our long-time partners Uni-President Enterprises Corporation and President Chain Store Corporation, both highly-recognized local operators, as we continue to grow in Taiwan. This is a critical next-step as we advance our multifaceted China growth strategy for long-term profitable growth in Asia.” East China is a significant and strategic region for Starbucks in China, with Shanghai containing nearly 600 stores, the largest number of stores globally of any city where Starbucks has a presence. In December 2017, Shanghai will also be the first city outside of the United States to welcome the opening of the ultra-premium Starbucks Reserve™ Roastery. “This is the beginning of yet another exciting new chapter for Starbucks in China. Full ownership will give us the opportunity to fully leverage our robust business infrastructure to deliver an elevated coffee, in-store third place experience and digital innovation to our customers, and further strengthen the career development opportunities for our people,” said Belinda Wong, ceo, Starbucks China. “Our East China partners’ relentless pursuit of operational excellence and leadership has provided us a solid foundation to maximize the unprecedented growth opportunities ahead and we look forward to extending our world-class network of unique programs to support their personal and professional dreams.” “We’ve had a strong friendship with Starbucks for nearly 20 years, starting with the opening of the first store in Taiwan and then further extending our partnership with the opening of the first store in East China,” said Alex Lo, chairman, Uni-President Enterprises Corporation. “We are confident that our new ownership model and continued collaboration with Starbucks will enable us to be even more focused on delivering an elevated Starbucks Experience to our customers in the Taiwan market.” Starbucks will discuss the financial impact of these transactions during its third quarter fiscal year 2017 earnings conference call at 2:00 p.m. PT today, Thursday, July 27. Both transactions are expected to close by early calendar year 2018 and are subject to customary closing conditions, including receipt of required regulatory approvals. Since 1971, Starbucks has been committed to ethically sourcing and roasting high-quality arabica coffee. Today, with stores around the globe, the company is the premier roaster and retailer of specialty coffee in the world. Through our unwavering commitment to excellence and our guiding principles, we bring the unique Starbucks Experience to life for every customer through every cup. To share in the experience, please visit us in our stores or online at www.starbucks.com. Uni-President Enterprises Corp. was established in 1967 and listed in 1987. We are not only the biggest food and beverage manufacturing company in Taiwan but also have business in China and Southeast Asia. We have also expanded our business scope to include retail and logistics so that we can provide the safest and the best experience to consumers by building vertical integration. To know more details about our company, please visit us online at www.uni-president.com.tw. Established in 1987 and listed on Taiwan Stock Exchange in 1997, President Chain Store Corp. (PCSC) is the largest convenience store operator in Taiwan, with over 5,100 7-ELEVEN stores at the end of 2016. PCSC has diversified into other retail businesses, such as restaurants, drugstores, department stores, supermarkets and online shopping. Our business operation areas include Taiwan, Mainland China, the Philippines and Japan. Uni-president, the largest food and beverage company in Taiwan, is PCSC’s parent company with 45.4% ownership. Certain statements contained herein are "forward-looking” statements within the meaning of the applicable securities laws and regulations. Generally, these statements can be identified by the use of words such as “anticipate,” “expect,” "believe," "could," "estimate," "feel," "forecast," "intend," "may," “plan," "potential," “project,” “should," “will," “would,” and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are based on information available to Starbucks as of the date hereof, and Starbucks actual results or performance could differ materially from those stated or implied, due to risks and uncertainties associated with its business. These risks and uncertainties include, but are not limited to, the failure of the parties to consummate the transactions due to commercial, regulatory or other reasons, as well as general economic and industry factors such as coffee, dairy and other raw materials pricing and availability, successful execution of internal performance and expansion plans, fluctuations in U.S., Chinese and other international economies and currencies, the impact of initiatives by competitors, the effect of legal proceedings, and other risks detailed in the Company's filings with the Securities and Exchange Commission, including the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended October 2, 2016. The Company assumes no obligation to update these forward-looking statements.
Totten V.,University Hospitals Case Medical Center |
Bellou A.,President University
Academic Emergency Medicine | Year: 2013
Emergency medicine (EM) is emerging worldwide. Its development as a recognized specialty is proceeding at difference rates in different countries. Europe is a region with complex political affiliations and is composed of countries both within and outside the European Union (EU). Europe is seeking greater standardization (harmonization) for mutually improved economic development. Medicine in general, and EM in particular, is no exception. In Europe, as in other regions, EM is struggling for acceptance as a valid field of specialization. The European Union of Medical Specialists requires that once two-fifths of countries acknowledge a specialty, all EU countries must address the question. EM had achieved the needed majority by 2011. This article briefly describes the European road to specialty acceptance. © 2013 by the Society for Academic Emergency Medicine.
Buzdar A.U.,President University |
Meric-Bernstam F.,The Surgical Center |
Leitch A.M.,University of Texas Southwestern Medical Center |
Ellis M.J.,University of Washington |
And 5 more authors.
The Lancet Oncology | Year: 2013
Background: Neoadjuvant chemotherapy with trastuzumab for patients with HER2-positive breast cancer can produce a pathological complete response in the breast in 30-65% of patients. We investigated the effect of the timing of trastuzumab administration with anthracycline and taxane neoadjuvant chemotherapy. Methods: This randomised trial was done at 36 centres in the USA and Puerto Rico. Women with operable HER2-positive invasive breast cancer were randomly assigned (1:1) with a biased coin minimisation algorithm, stratified for age, tumour size, and hormone receptor status. Neither patients nor investigators (except for a cardiac safety review panel) were masked to treatment assignment. Patients randomly assigned to sequential treatment received fluorouracil 500 mg/m2, epirubicin 75 mg/m2, and cyclophosphamide 500 mg/m2 (FEC-75) on day 1 of a 21-day cycle for four cycles followed by paclitaxel 80 mg/m2 and trastuzumab 2 mg/kg (after a 4 mg/kg loading dose) once per week for 12 weeks, while those randomly assigned to the concurrent treatment group received paclitaxel and trastuzumab once per week for 12 weeks followed by four cycles of FEC-75 (on day 1 of each 21-day cycle) and once-weekly trastuzumab, in the same doses as the sequential group. Surgery, including evaluation of the axilla, was done within 6 weeks of completion of neoadjuvant treatment. The primary outcome was the percentage of patients who had a pathological complete response in the intention-to-treat population. The study is registered with ClinicalTrials.gov, number NCT00513292. Findings: From Sept 15, 2007, to Dec 15, 2011, 282 women were enrolled (140 in the sequential group, 142 in the concurrent group). Two patients in the sequential group withdrew consent before starting treatment. 78 of 138 (56·;5%, 95% CI 47·;8-64·;9) patients who received sequential treatment had a pathological complete response in the breast versus 77 of 142 (54·;2%, 95% CI 45·;7-62·;6) who received concurrent treatment (difference 2·;3%, 95% CI -9·;3 to 13·;9). No treatment-related deaths occurred. The most common severe toxic effects were neutropenia (35 [25·;3%] of 138 patients in the sequential group vs 45 [31·;7%] of 142 patients in the concurrent group) and fatigue (six [4·;3%] vs 12 [8·;5%]). Left ventricular ejection fraction dropped below the institutional lower limit of normal at week 12 in one (0·;8%) of 130 patients who received sequential treatment and four (2·;9%) of 137 patients who received concurrent treatment; by week 24, it had dropped below this limit in nine (7·;1%) of 126 patients and in six (4·;6%) of 130 patients, respectively. Interpretation: Concurrent administration of trastuzumab with anthracyclines offers no additional benefit and is not warranted. Funding: US National Cancer Institute. © 2013 Elsevier Ltd.
News Article | November 2, 2016
DALLAS, TX--(Marketwired - November 02, 2016) - The Board of Trustees, Faculty, Staff, Students, and Alumni of Parker University are pleased to announce and celebrate the inauguration of their new president, William E. Morgan, DC. As the seventh president of Parker University, Dr. Morgan will begin his term presiding over an expanding roster of both programs and students as Parker University pursues its mission of comprehensive education dedicated to research, service, and education. The inauguration was held at 1:30pm on the Parker University main campus in Dallas, Texas at the Standard Process Student Activity Center on October 7, 2016. General Walter E. Boomer was present as a special guest of the president, who invited him to make a special presentation on his behalf. General Boomer is a retired four-star general and assistant commandant of the United States Marine Corps and a business executive. He led all Marines in Operations Desert Shield and Desert Storm during the Gulf War. He later served as the Chairman and CEO of Rogers Corporation, retiring in 2004. He is the current lead director of Baxter International. General Boomer is a 1960 graduate of Duke University; he later earned a master's degree from American University. In 1998, Dr. Morgan was chosen to establish the first chiropractic clinic at the National Naval Medical Center in Bethesda, Maryland, which later became Walter Reed National Military Medical Center. In 2015, Walter Reed recognized Dr. Morgan with its highest honor for clinical excellence, the Master Clinician's Award. During the last 18 years at the military's most prestigious medical centers, he practiced in an integrative setting providing chiropractic care to the injured troops returning from the wars in Iraq and Afghanistan. In a note to the Parker Board Chair from Admiral Mike Mullen, USN (retired) 17th Chairman of the Joint Chiefs of Staff, he remarks, "I am writing to express my warmest congratulations on your selection of Dr. Bill Morgan as the next president of Parker University. You simply could not have made a better choice. I have known Bill as a matchless student and practitioner of his profession over the past 13 years. He has had an enormous positive impact on thousands of lives. This impact has been that much more significant during over a decade of war where he has innovated and been on the leading edge of chiropractic practice in sometimes overwhelming circumstances. Bill is personable, studied, and dedicated beyond the call. You truly will be blessed in his service and we will miss him immensely here in Bethesda." Dr. Morgan was appointed as the Chiropractic Consultant to the Office of Attending Physician (OAP) at the U.S. Capitol in 2000. At the OAP, doctors of many specialties care for members of Congress and the Supreme Court. Since 2007, Dr. Morgan has served as the Chiropractic Consultant to the White House. He was appointed chiropractor for the United States Naval Academy football team in 2009. Parker University's Chairman of the Board, Oliver "Bud" Smith, Jr. DC, said "The Board of Trustees selected Dr. Morgan based on his depth of experience as a doctor of chiropractic, alongside his continued involvement in almost every aspect of the profession, including but not limited to his ability to integrate chiropractic into mainstream health care," states Dr. Smith. He continues, "Dr. Morgan's comprehensive skill-set will certainly lead Parker University students, faculty and alumni toward a successful future, and we are honored to appoint him as our President." In 1985, Dr. Morgan received his Doctorate of Chiropractic from Palmer College of Chiropractic - West Campus and soon after, married fellow Palmer graduate, Clare Pelkey. They practiced for 13 years in California. He has completed a 2,000 hour fellowship program in Integrated Medicine. Since 2006, Dr. Morgan has served on the Board of Trustees for Palmer College of Chiropractic. He is also a Diplomate of the American Academy of Pain Management and holds adjunct faculty positions at F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences and New York Chiropractic College. Additionally, Dr. Morgan has served as a consultant for the U.S. Department of Veterans Affairs (VA), helping to implement the VA's chiropractic benefit and advocate for chiropractic research. In 2011, Dr. Morgan was appointed to the United States Navy Musculoskeletal Continuum of Care Advisory Board -- an entity created to address the prevalent injuries sustained by U.S. Armed Forces Personnel during active-duty operations. Dr. Morgan also served on the Spine Subcommittee, which helps develop care algorithms for treating spinal conditions and determining the future of musculoskeletal management in the U.S. Armed Forces. Dr. Morgan has a long history of serving in military health care. Joining the Navy at 17, he served with an elite Marine Recon company as a hospital corpsman. While in the Navy, he was qualified in parachuting, military diving, submarine insertion, jungle warfare, combat swimming, explosives, mountaineering, winter warfare and Arctic survival. Additionally, he attended anti-terrorist training at the FBI Academy. After leaving active military service and transferring to the Navy Reserves, Dr. Morgan began his educational journey to becoming a doctor of chiropractic. While at Palmer College of Chiropractic, he transferred to a Naval Special Warfare platoon as the unit's primary hospital corpsman. He was sent to Special Operations Technician training to learn the principles of dive medicine. For the next eight years, he served as a dive medicine corpsman/combat swimmer for a platoon of Navy frogmen in Navy Special Warfare Unit One. Excited about his new position, Dr. Morgan states, "Dr. Jim Parker created a chiropractic college in 1982 with a unique spirit, adhering to the rich philosophy, art and emerging science of his profession and with a strong mission. As the new President of Parker University, it is my goal to work toward continuing Dr. Parker's vision for the university, with special emphasis on his passion for education, entrepreneurship, healing, self-actualization and personal responsibility. Dr. Jim Parker's focus on service is epitomized in my favorite Albert Schweitzer quote, 'I don't know what your destiny will be, but one thing I know: The only ones among you who will be really happy are those who will have sought and found how to serve.'" In 2011, Parker achieved University status, paving the way for new health care degree programs that expand students' scope of knowledge and provide additional opportunities for Parker graduates to serve more people around the world. Parker University equips its graduates in health sciences, technology, business, and education communities to establish trends in health care and wellness through its certificate, associates, bachelors, masters, and doctoral degrees. Parker University provides an innovative, learning-centered experience for students through a comprehensive curriculum, highly respected faculty, and family-oriented environment. Dallas-based Parker University, formerly known as Parker College of Chiropractic, is one of the world's leading educators of health care professionals. Founded in 1982, this private, nonprofit, educational institution prepares men and women to become doctors of chiropractic and other leaders in health care-related professions. Parker University offers 12 different degree programs as well as continuing education specializations and certifications. Parker University also includes the Parker Research Institute, which provides sound, scientific evidence supporting health and wellness; two chiropractic wellness clinics in the Dallas-Fort Worth Metroplex; Parker Seminars, the largest chiropractic seminar organization in the world, and Parker SHARE Products that provide innovative, high quality products, and current information on chiropractic wellness. For additional information about Parker University, visit the website at www.parker.edu.
Kuehn K.A.,University of Southern Mississippi |
Francoeur S.N.,Eastern Michigan University |
Findlay R.H.,University of Alabama |
Neely R.K.,Eastern Michigan University |
Neely R.K.,President University
Ecology | Year: 2014
Microbial communities associated with submerged detritus in aquatic ecosystems often comprise a diverse mixture of autotrophic and heterotrophic microbes, including algae, bacteria, protozoa, and fungi. Recent studies have documented increased rates of plant litter mass loss when periphytic algae are present. We conducted laboratory and field experiments to assess potential metabolic interactions between natural autotrophic and heterotrophic microbial communities inhabiting submerged decaying plant litter of Typha angustifolia and Schoenoplectus acutus. In the field, submerged plant litter was either exposed to natural sunlight or placed under experimental canopies that manipulated light availability and growth of periphytic algae. Litter was collected and returned to the laboratory, where algal photosynthesis was manipulated (light/dark incubation), while rates of bacterial and fungal growth and productivity were simultaneously quantified. Bacteria and fungi were rapidly stimulated by exposure to light, thus establishing the potential for algal priming of microbial heterotrophic decay activities. Experimental incubations of decaying litter with 14C- and 13C-bicarbonate established that inorganic C fixed by algal photosynthesis was rapidly transferred to and assimilated by heterotrophic microbial decomposers. Periphytic algal stimulation of microbial heterotrophs, especially fungal decomposers, is an important and largely unrecognized interaction within the detrital microbial landscape, which may transform our current conceptual understanding of microbial secondary production and organic matter decomposition in aquatic ecosystems. © 2014 by the Ecological Society of America.
Bendraou R.,University Pierre and Marie Curie |
Jezequel J.-M.,French Institute for Research in Computer Science and Automation |
Gervais M.-P.,President University |
Blanc X.,University Pierre and Marie Curie
IEEE Transactions on Software Engineering | Year: 2010
Describing and managing activities, resources, and constraints of software development processes is a challenging goal for many organizations. A first generation of Software Process Modeling Languages (SPMLs) appeared in the 1990s but failed to gain broad industrial support. Recently, however, a second generation of SPMLs has appeared, leveraging the strong industrial interest for modeling languages such as UML. In this paper, we propose a comparison of these UML-based SPMLs. While not exhaustive, this comparison concentrates on SPMLs most representative of the various alternative approaches, ranging from UML-based framework specializations to full-blown executable metamodeling approaches. To support the comparison of these various approaches, we propose a frame gathering a set of requirements for process modeling, such as semantic richness, modularity, executability, conformity to the UML standard, and formality. Beyond discussing the relative merits of these approaches, we also evaluate the overall suitability of these UML-based SPMLs for software process modeling. Finally, we discuss the impact of these approaches on the current state of the practice, and conclude with lessons we have learned in doing this comparison. © 2010 IEEE.
Papayannopoulou T.,University of Washington |
Kaushansky K.,President University
Experimental Hematology | Year: 2016
Although the synergy between erythropoietin and thrombopoietin has previously been pointed out, the clonal demonstration of a human bipotent erythroid/megakaryocytic progenitor (MEP) was first published in Experimental Hematology (Papayannopoulou T, Brice M, Farrer D, Kaushansky K. Exp Hematol. 1996;24:660–669) and later in the same year in Blood (Debili N, Coulombel L, Croisille L, et al. Blood. 1996;88:1284–1296). This demonstration, and the fact that both bipotent and monopotent erythroid or megakaryocytic progenitors co-express markers of both lineages and respond to both lineage-specific transcription factors, has provided a background for the extensive use of MEP assessment by fluorescence-activated cell sorting in many subsequent studies. Beyond this, the demonstration of shared regulatory elements and the presence of single mutations affecting both lineages have inspired further studies to decipher how the shift in transcription factor networks occurs from one lineage to the other. Furthermore, in addition to shared effects, erythropoietin and thrombopoietin have additional independent effects. Most notable for thrombopoietin is its effect on hematopoietic stem cells illustrated by in vitro and in vivo approaches. © 2016 ISEH - International Society for Experimental Hematology
Sitompul E.,President University
Proceedings of International Conference on Computational Intelligence, Modelling and Simulation | Year: 2013
A new scheme for adaptive neural networks for nonlinear dynamic system identification is proposed in this paper. The network of structure multi-layer perceptron with external recurrence is trained offline at first to get the initial network parameters. The parameters of the network are classified into short-term memory part and long-term memory part. The short-term memory part includes the parameters which are linear to the network output. In the implementation, the network is validated in each sampling time using a set of new measurement data. Training procedure will be executed if the model error exceeds a specified value and the short-term memory part will be adjusted. The application in modelling of room thermal behaviour demonstrates the performance of the proposed scheme. © 2013 IEEE.
President University | Date: 2014-01-22
A coral extract for skin whitening, moisture retention, elasticity improvement, anti-inflammation and occlusion of wounds and its extracting method is provided. The coral extract is extracted from Briareum excavatum. The extracting method comprises: extracting with organic solvents, partitioning with water and ethyl acetate and separating via column chromatography. The coral extract can be applied in the field of skin whitening, moisture retention, elasticity improvement, anti-inflammation and occlusion of wounds.
President University | Date: 2012-07-11
A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of Zingiber Officinale, Olibanum and Myrrha. The preparation method for the Chinese herbal medicine composition comprises the following steps: adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extratum.